Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

FINGOLIMOD PHARMATHEN 0,5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/FINGOLIMOD PHARMATHEN 0,5 MG CAPSULAS DURAS EFG

Approved

STANDARD

FINGOLIMOD PHARMATHEN 0,5 MG CAPSULAS DURAS EFG

Pharmathen S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 20, 2020
Approval ID: eaf462cb7b26f203
Company: Pharmathen S.A.
Type: Standard

Approval Details

Approval Id: eaf462cb7b26f203
Drug Cima Aemps Name: FINGOLIMOD PHARMATHEN 0,5 MG CAPSULAS DURAS EFG
Register Number: 85499
Holder Company Name: Pharmathen S.A.
Marketing Company Name: Pharmathen S.A.
Holder Company Detail Path: /organization/pharmathen-s-a
Marketing Company Detail Path: /organization/pharmathen-s-a
Authorization Date: 2020-10-20
Dosage Form: CÁPSULA DURA
Dose: 0.5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Pharmathen S.A.
Company Detail Path: /organization/pharmathen-s-a

Company Information

Pharmaceutical Company Name: PHARMATHEN S.A.
Country Name: Greece
City Name: pallini,sterea ellada and evoia,country_gr
Address: 6 Dervenakion

Active Ingredients

FINGOLIMOD HIDROCLORURO

0,56 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 20, 2020

Approval ID

eaf462cb7b26f203

Type

Standard

Back to CIMA-AEMPS Approvals